S R Wiley
Overview
Explore the profile of S R Wiley including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
1505
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
McCamy C, Wiley S, Speckman J
J Res Natl Bur Stand A Phys Chem
. 2020 Jan;
73A(1):79-99.
PMID: 31929617
As part of an investigation of the formation of six types of redox blemishes on microfilm, 7411 rolls of microfilmed records in 36 Federal Government agencies were microscopically inspected by...
2.
Wiley S, Cassiano L, Lofton T, Winkles J, Lindner V, Liu H, et al.
Immunity
. 2001 Dec;
15(5):837-46.
PMID: 11728344
TWEAK is a member of the TNF ligand family that induces angiogenesis in vivo. We report cloning of a receptor for TWEAK (TweakR) from a human umbilical vein endothelial cell...
3.
Sedger L, Shows D, Blanton R, Peschon J, Goodwin R, Cosman D, et al.
J Immunol
. 1999 Jul;
163(2):920-6.
PMID: 10395688
TNF-related apoptosis-inducing ligand (TRAIL) is able to kill many transformed cells of diverse tissue types. We show that TRAIL is inducible by IFN-gamma, by TNF-alpha, and by infection with human...
4.
Griffith T, Wiley S, Kubin M, Sedger L, Maliszewski C, Fanger N
J Exp Med
. 1999 Apr;
189(8):1343-54.
PMID: 10209050
TRAIL (tumor necrosis factor [TNF]-related apoptosis-inducing ligand) is a molecule that displays potent antitumor activity against selected targets. The results presented here demonstrate that human monocytes rapidly express TRAIL, but...
5.
Wiley S
Curr Pharm Des
. 1999 Apr;
4(5):417-22.
PMID: 10197053
The term genomics has evolved into a catch-all term for a variety of information intensive biological methodologies. While the promise of genomics in the bio/pharmaceutical industry is great, its impact...
6.
Lynch C, Wang Y, Lund J, Chen Y, Leal J, Wiley S
J Biol Chem
. 1999 Mar;
274(13):8455-9.
PMID: 10085077
TWEAK is a recently described member of the Tumor Necrosis Factor (TNF) ligand family whose transcripts are present in a wide variety of human tissues (Chicheportiche, Y., Bourdon, P. R.,...
7.
Johnston S, Liu X, Zuo F, Eisenbraun T, Wiley S, Kraus R, et al.
Mol Endocrinol
. 1997 Mar;
11(3):342-52.
PMID: 9058380
The human estrogen-related receptor alpha 1 (hERR alpha 1) is an orphan member of the steroid/thyroid hormone receptor superfamily. A cDNA encoding this protein was originally isolated on the basis...
8.
Wiley S, Goodwin R, Smith C
J Immunol
. 1996 Oct;
157(8):3635-9.
PMID: 8871664
CD30 ligand (CD30L), a member of the TNF family, is a type II membrane protein with a C-terminal extracellular domain that is homologous with the extracellular domains of other TNF...
9.
Kraus R, Murray E, Wiley S, Zink N, Loritz K, Gelembiuk G, et al.
Nucleic Acids Res
. 1996 Apr;
24(8):1531-9.
PMID: 8628688
The basal elements of class II promoters are: (i) a-30 region, recognized by TATA binding protein (TBP); (ii) an initiator (Inr) surrounding the start site for transcription; (iii) frequently a...
10.
Wiley S, Schooley K, Smolak P, Din W, Huang C, Nicholl J, et al.
Immunity
. 1995 Dec;
3(6):673-82.
PMID: 8777713
A novel tumor necrosis factor (TNF) family member has been cloned and characterized. This protein, designated TNF-related apoptosis-inducing ligand (TRAIL), consists of 281 and 291 aa in the human and...